advertisement
Gupta V 18
Showing records 1 to 18 | Display all abstracts from Gupta V94982 Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma
Naik M
Clinical Ophthalmology 2021; 15: 2683-2692
95436 In vivo imaging of the Schlemm's Canal and the response to Selective laser trabeculoplasty
Varshney T
American Journal of Ophthalmology 2022; 234: 126-137
95286 Retinal changes in Alzheimer's disease- integrated prospects of imaging, functional and molecular advances
Gupta VB
Progress in Retinal and Eye Research 2021; 82: 100899
94982 Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma
Kapur M
Clinical Ophthalmology 2021; 15: 2683-2692
95436 In vivo imaging of the Schlemm's Canal and the response to Selective laser trabeculoplasty
Azmira K
American Journal of Ophthalmology 2022; 234: 126-137
95286 Retinal changes in Alzheimer's disease- integrated prospects of imaging, functional and molecular advances
Chitranshi N; den Haan J
Progress in Retinal and Eye Research 2021; 82: 100899
95436 In vivo imaging of the Schlemm's Canal and the response to Selective laser trabeculoplasty
Gupta S
American Journal of Ophthalmology 2022; 234: 126-137
94982 Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma
Gupta V
Clinical Ophthalmology 2021; 15: 2683-2692
95286 Retinal changes in Alzheimer's disease- integrated prospects of imaging, functional and molecular advances
Mirzaei M
Progress in Retinal and Eye Research 2021; 82: 100899
95436 In vivo imaging of the Schlemm's Canal and the response to Selective laser trabeculoplasty
Mahalingam K
American Journal of Ophthalmology 2022; 234: 126-137
94982 Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma
Sethi H
Clinical Ophthalmology 2021; 15: 2683-2692
95436 In vivo imaging of the Schlemm's Canal and the response to Selective laser trabeculoplasty
Singh A
American Journal of Ophthalmology 2022; 234: 126-137
94982 Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma
Srivastava K
Clinical Ophthalmology 2021; 15: 2683-2692
95286 Retinal changes in Alzheimer's disease- integrated prospects of imaging, functional and molecular advances
You Y; Lim JK
Progress in Retinal and Eye Research 2021; 82: 100899
95436 In vivo imaging of the Schlemm's Canal and the response to Selective laser trabeculoplasty
Angmo D
American Journal of Ophthalmology 2022; 234: 126-137
95286 Retinal changes in Alzheimer's disease- integrated prospects of imaging, functional and molecular advances
Basavarajappa D
Progress in Retinal and Eye Research 2021; 82: 100899
95436 In vivo imaging of the Schlemm's Canal and the response to Selective laser trabeculoplasty
Gupta V
American Journal of Ophthalmology 2022; 234: 126-137
95286 Retinal changes in Alzheimer's disease- integrated prospects of imaging, functional and molecular advances
Godinez A; Di Angelantonio S; Sachdev P; Salekdeh GH; Bouwman F; Graham S; Gupta V
Progress in Retinal and Eye Research 2021; 82: 100899
